Spiriva Respimat
Payments companies reported to CMS as associated with Spiriva Respimat. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Spiriva Respimat, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Spiriva Respimat
These are the largest totals companies reported as associated with Spiriva Respimat. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Yolanda Mageto | Dallas, TX | Pulmonary Disease | $3,600.00 |
| Reynold Panettieri | New Brunswick, NJ | Pulmonary Disease | $3,600.00 |
| Sanjay Sethi | Buffalo, NY | Internal Medicine | $3,000.00 |
| Ravi Kalhan | Chicago, IL | Pulmonary Disease | $3,000.00 |
| Haley Hoy | Nashville, TN | Acute Care (Nurse Practitioner) | $2,460.00 |
| Eric Teller | Hackensack, NJ | Critical Care Medicine (Internal Medicine) | $623.63 |
| Gerard Criner | Philadelphia, PA | Pulmonary Disease | $600.00 |
| Singwu Law | New York, NY | Critical Care Medicine (Internal Medicine) | $569.65 |
| Kenneth Sha | Flushing, NY | Pulmonary Disease | $538.08 |
| Kelly Tabor | Hendersonville, TN | Family | $526.70 |
Prescribed Spiriva Respimat?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.